Kapil Dhingra - Net Worth and Insider Trading
Kapil Dhingra Net Worth
The estimated net worth of Kapil Dhingra is at least $0 dollars as of 2024-09-20. Kapil Dhingra is the Director of Replimune Group Inc and owns about 0 shares of Replimune Group Inc (REPL) stock worth over $0. Details can be seen in Kapil Dhingra's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kapil Dhingra has not made any transactions after 2020-12-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kapil Dhingra
Kapil Dhingra Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kapil Dhingra owns 3 companies in total, including Five Prime Therapeutics Inc (FPRX) , Replimune Group Inc (REPL) , and Black Diamond Therapeutics Inc (BDTX) .
Click here to see the complete history of Kapil Dhingra’s form 4 insider trades.
Insider Ownership Summary of Kapil Dhingra
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FPRX | Five Prime Therapeutics Inc | 2020-05-14 | director |
| REPL | Replimune Group Inc | 2020-12-07 | director |
| BDTX | Black Diamond Therapeutics Inc | 2021-01-19 | director |
Kapil Dhingra Latest Holdings Summary
Kapil Dhingra currently owns a total of 1 stock. Kapil Dhingra owns 0 shares of Replimune Group Inc (REPL) as of December 7, 2020, with a value of $0.
Latest Holdings of Kapil Dhingra
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| REPL | Replimune Group Inc | 2020-12-07 | 0 | 11.24 | 0 |
Holding Weightings of Kapil Dhingra
Kapil Dhingra Form 4 Trading Tracker
According to the SEC Form 4 filings, Kapil Dhingra has made a total of 1 transactions in Replimune Group Inc (REPL) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Replimune Group Inc is the sale of 40,000 shares on December 7, 2020, which brought Kapil Dhingra around $2 Million.
Insider Trading History of Kapil Dhingra
- 1
Kapil Dhingra Trading Performance
Kapil Dhingra Ownership Network
Kapil Dhingra Owned Company Details
What does Five Prime Therapeutics Inc do?
Who are the key executives at Five Prime Therapeutics Inc?
Kapil Dhingra is the director of Five Prime Therapeutics Inc. Other key executives at Five Prime Therapeutics Inc include 10 percent owner Biotechnology Value Fund L P , 10 percent owner Bvf Inc/il , and 10 percent owner Bvf Gp Holdings Llc .
Five Prime Therapeutics Inc (FPRX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Five Prime Therapeutics Inc (FPRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Five Prime Therapeutics Inc (FPRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Five Prime Therapeutics Inc (FPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Five Prime Therapeutics Inc Insider Transactions
Kapil Dhingra Mailing Address
Above is the net worth, insider trading, and ownership report for Kapil Dhingra. You might contact Kapil Dhingra via mailing address: 39 Bliss Avenue, Tenafly Nj 07670.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
